CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.
July 19th 2024
Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data.
Importance and the Process of PSMA PET Imaging in mCRPC
July 1st 2022Jeremie Calais, MD, comments on how PSMA PET scans have changed the treatment landscape for patients with mCRPC and describes the process for obtaining a PSMA PET scan, including what patients should know before, during and after the scan.
Zytiga-Containing Regimen Boosts Survival in Certain Patients With Prostate Cancer
May 6th 2022Treatment with androgen deprivation therapy in combination with Zytiga, docetaxel and prednisone improved radiographic progression-free survival and overall survival in patients with de novo metastatic castration-sensitive prostate cancer.
FDA Expedites Review of Nubeqa Combination for Metastatic, Hormone-Sensitive Prostate Cancer
May 3rd 2022Results from a phase 3 trial showed that the combination of Nubeqa, docetaxel and androgen-deprivation therapy significantly decreased the risk of death for men with a certain type of prostate cancer.
Male Cancer Caregivers Navigate A Gauntlet of Challenges, Often Under The Cover of Darkness
March 15th 2022Regardless of a man’s age, providing care to a partner or family member with cancer has been shown to take a drastic toll on their health. To make matters worse, research shows many men struggle in silence.